Biovie submitted trial data to the U.S. Food and Drug Administration and announced results from its offices in Carson City, Nev.
2 reports, 2 independent
Updated Aug 6
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Biovie submitted trial data to the U.S. Food and Drug Administration and announced results from its offices in Carson City, Nev.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Biovie
French company founded in 2007, specializing in online sales of organic, raw, and living foods, committed to education on healthy eating.
Nothing else this week.
- FDA
-
Nasdaq
American fully electronic stock exchange
Related events
- Capricor Therapeutics is seeking regulatory approval from the FDA for clinical trials and has listed on the Nasdaq stock exchange, with a law firm based in New York City involved.
- Decoy Therapeutics is listed on the Nasdaq stock exchange and is currently seeking expedited regulatory approval via FDA pathways.
- Cardiol Therapeutics Inc. is listed on Nasdaq and is developing therapy for an FDA-approved indication.
- HCW Biologics announced it is listed on the Nasdaq stock exchange.
- Alvotech utilized Nasdaq for its public stock listing and is currently undergoing comprehensive review by the FDA for biosimilar applications.